background
mesenchym
stem
stromal
cell
msc
mediat
immunoregulatori
tissu
repair
function
secret
paracrin
factor
includ
extracellular
vesicl
ev
sever
anim
model
human
diseas
mscev
mimic
benefici
effect
msc
influenza
virus
caus
annual
outbreak
acut
respiratori
ill
result
signific
mortal
morbid
influenza
virus
constantli
evolv
thu
gener
drugresist
strain
render
current
vaccin
less
effect
newli
gener
strain
therefor
new
therapi
control
viru
replic
inflammatori
respons
host
need
object
studi
examin
mscev
treatment
attenu
influenza
virusinduc
acut
lung
injuri
preclin
model
method
isol
ev
swine
bone
marrowderiv
msc
morpholog
mscev
determin
electron
microscopi
express
mesenchym
marker
examin
flow
cytometri
next
examin
antiinfluenza
activ
mscev
vitro
lung
epitheli
cell
antivir
immunomodulatori
properti
vivo
pig
model
influenza
viru
result
mscev
isol
msccondit
medium
ultracentrifug
mscev
roundshap
similarli
msc
express
mesenchym
marker
lack
express
swine
leukocyt
antigen
ii
incub
ev
lung
epitheli
cell
reveal
mscev
incorpor
epitheli
cell
next
examin
antiinfluenza
antiinflammatori
properti
mscev
mscev
inhibit
hemagglutin
activ
avian
swine
human
influenza
virus
concentr
mscev
inhibit
influenza
viru
replic
virusinduc
apoptosi
lung
epitheli
cell
antiinfluenza
activ
mscev
due
transfer
rna
ev
epitheli
cell
sinc
preincub
mscev
rnase
enzym
abrog
antiinfluenza
activ
mscev
pig
model
influenza
viru
intratrach
administr
mscev
h
influenza
viru
infect
significantli
reduc
viru
shed
nasal
swab
influenza
viru
replic
lung
virusinduc
product
proinflammatori
cytokin
lung
influenzainfect
pig
histopatholog
find
reveal
mscev
allevi
influenza
virusinduc
lung
lesion
pig
continu
next
page
conclus
data
demonstr
relev
preclin
larg
anim
model
influenza
viru
mscev
possess
antiinfluenza
antiinflammatori
properti
ev
may
use
cellfre
therapi
influenza
human
keyword
mesenchym
stem
cell
extracellular
vesicl
influenza
acut
lung
injuri
stem
cell
therapi
larg
anim
model
background
influenza
virus
iav
caus
acut
respiratori
diseas
human
anim
annual
outbreak
occasion
pandem
influenza
result
million
death
suffer
econom
loss
us
alon
sinc
influenza
virus
caus
hospit
result
death
annual
http
wwwcdcgovfluaboutdiseaseburdenhtm
elderli
infant
peopl
underli
condit
high
risk
influenzaassoci
mortal
addit
season
pandem
virus
highli
pathogen
avian
influenza
hpai
viru
repeatedli
transmit
directli
avian
speci
human
human
viru
associ
sever
diseas
result
multiorgan
failur
high
mortal
rate
octob
hpai
virus
caus
human
infect
result
death
sinc
http
ua
sever
case
influenza
caus
signific
mortal
due
abil
induc
cytokinemedi
immun
lung
patholog
featur
moder
sever
acut
respiratori
distress
syndrom
ard
influenza
viru
infect
gener
control
annual
vaccin
howev
vaccin
provid
limit
protect
new
reassort
genet
differ
vaccin
viru
event
pandem
gener
new
vaccin
contain
circul
virus
take
approxim
month
moreov
influenza
virus
continu
undergo
mutat
result
gener
new
viral
strain
becom
resist
current
avail
antivir
drug
thu
altern
therapi
capabl
inhibit
influenza
viru
replic
attenu
inflammatori
respons
host
need
mesenchym
stem
stromal
cell
msc
multipot
cell
first
identifi
bone
marrow
bm
plastic
adher
fibroblastlik
cell
msc
possess
multilineag
differenti
immunomodulatori
tissu
repair
properti
due
properti
msc
attract
cellular
therapi
inflammatori
autoimmun
diseas
regen
medicin
sever
studi
ard
anim
model
shown
benefici
effect
msc
administr
clinic
trial
shown
feasibl
msc
administr
patient
ard
therapeut
studi
underway
similarli
ard
sever
influenza
viru
infect
human
anim
model
show
acut
inflammatori
respons
lung
damag
msc
suppress
inflamm
tissu
repair
regen
abil
ard
influenza
appropri
target
msc
therapi
howev
msc
therapi
mice
model
influenza
show
inconsist
result
also
other
shown
influenza
viru
infect
msc
infect
may
alter
immunoregulatori
differenti
properti
msc
sever
studi
indic
benefici
action
msc
due
releas
paracrin
factor
sinc
transplant
msc
engraft
site
injuri
recent
extracellular
vesicl
ev
includ
exosom
exo
releas
multivesicular
bodi
microvesicl
mv
shed
cell
surfac
apoptot
bodi
identifi
msc
secret
paper
ev
exo
mv
collect
refer
ev
mscderiv
ev
similar
express
surfac
molecul
contain
mscspecif
protein
mrna
microrna
mirna
organel
lipid
diseas
tissu
mscev
interact
injur
cell
transfer
protein
mrna
bioactiv
lipid
msc
injur
cell
result
tissu
repair
rodent
model
ev
therapeut
efficaci
msc
e
coli
endotoxininduc
acut
lung
injuri
ali
e
coliinduc
sever
pneumonia
mice
due
close
similar
anatomi
physiolog
immunolog
human
pig
use
larg
anim
preclin
model
sever
human
diseas
includ
respiratori
diseas
regen
medicin
addit
pig
natur
infect
influenza
viru
respiratori
epithelium
pig
express
receptor
util
avian
mammalian
influenza
virus
influenza
viru
pathogenesi
clinic
sign
pig
also
similar
observ
human
thu
pig
suitabl
larg
anim
model
studi
human
influenza
viru
pathogenesi
test
efficaci
therapeut
includ
msc
deriv
influenza
msc
femur
bone
commerci
pig
isol
describ
previous
briefli
tip
bone
remov
marrow
harvest
insert
syring
needl
one
end
bone
flush
dulbecco
modifi
eagl
medium
dmem
gibco
bm
cell
filter
nylon
mesh
filter
bd
falcon
usa
mononuclear
cell
obtain
densiti
gradient
centrifug
ficollhypaqu
cell
cm
plate
cell
cultur
flask
dmem
contain
fetal
bovin
serum
fb
gibco
antibiot
solut
gibco
cdmem
cultur
incub
humidifi
atmospher
contain
air
co
nonadher
cell
remov
h
cultur
cell
passag
confluent
treat
trypsin
contain
edta
msc
passag
three
five
time
use
gener
mscev
vitro
vivo
experi
isol
mscev
msc
cultur
cdmem
flask
mscev
isol
previous
describ
briefli
cell
confluent
wash
serumfre
dmem
cultur
dmem
contain
bovin
serum
albumin
h
condit
medium
cm
msc
cultur
collect
centrifug
rpm
min
remov
cellular
debri
next
cm
ultracentrifug
rpm
min
ev
pellet
wash
dmem
ultracentrifug
rpm
min
ev
pellet
suspend
phosphatebuff
salin
pb
pbsmillion
msc
dilut
made
serumfre
dmem
protein
content
ev
determin
microbicinchonin
acid
protein
assay
kit
thermofish
scientif
mscev
rna
isol
use
rnaeasi
kit
qiagen
rna
concentr
determin
nanodrop
thermofish
scientif
ev
appli
formvarcarbonco
grid
min
blot
grid
stain
aqueou
uranyl
acet
min
blot
grid
airdri
examin
tem
hitachi
japan
msc
ev
examin
surfac
express
mesenchym
marker
swine
leukocyt
antigen
sla
slaii
ev
also
examin
ev
marker
flow
cytometri
describ
previous
ev
pb
incub
diamet
aldehydesulf
latex
bead
min
room
temperatur
follow
addit
ml
pb
incub
continu
h
gentl
shake
reaction
stop
incub
min
mm
glycin
msc
detach
treatment
trypsinedta
singl
cell
suspens
msc
evcoat
bead
stain
follow
primari
antibodi
mous
antipig
mous
antihuman
bd
bioscienc
mous
antipig
slai
slaii
vmrd
detect
ev
marker
evcoat
bead
stain
follow
primari
antibodi
crossreact
pig
mous
antihuman
genetex
mous
antihuman
bd
bioscienc
mous
antihuman
bd
bioscienc
min
dark
cell
bead
wash
three
time
incub
secondari
antibodi
conjug
allophycocyanin
phycoerythrin
min
appropri
isotyp
secondari
antibodi
use
control
nonspecif
bind
cell
bead
acquir
flow
cytomet
bd
accuri
cytomet
analyz
use
plu
softwar
accuri
describ
previous
examin
whether
mscev
abil
enter
cell
use
pig
lung
epitheli
cell
lec
spontan
immort
cell
line
establish
laboratori
cell
line
deriv
distal
trachea
proxim
lung
tissu
pig
cell
express
sialic
acid
receptor
avian
mammalian
influenza
virus
respect
support
replic
swine
avian
humanorigin
influenza
virus
unpublish
result
mscev
label
use
red
fluoresc
cell
linker
kit
sigmaaldrich
per
manufactur
instruct
lec
cultur
overnight
plate
incub
label
mscev
h
confirm
intern
ev
insid
cell
cell
cytoplasm
stain
use
polyclon
rabbit
antihuman
primari
antibodi
thermofish
scientif
alexa
goat
antirabbit
secondari
antibodi
thermofish
scientif
cell
nuclei
stain
dapi
thermofish
scientif
life
scienc
cell
examin
fluoresc
microscop
olympu
japan
flow
cytometri
singl
cell
suspens
obtain
treat
cell
trypsinedta
wash
pb
cell
acquir
flow
cytomet
bd
accuri
cytomet
incorpor
label
ev
cell
analyz
plu
softwar
accuri
effect
mscev
abil
influenza
viru
hemagglutin
red
blood
cell
examin
hemagglutin
inhibit
assay
twofold
dilut
mscev
start
volum
mix
hemagglutin
ha
unit
swine
avian
human
influenza
virus
incub
min
follow
addit
turkey
red
blood
cell
suspens
plate
incub
min
room
temperatur
concentr
mscev
capabl
inhibit
ha
activ
differ
influenza
virus
determin
examin
effect
mscev
influenza
viru
replic
two
set
experi
conduct
first
set
incub
swiv
equival
moi
mscev
min
room
temperatur
lec
cultur
overnight
infect
swiv
alon
virusmscev
mixtur
h
cell
wash
pb
incub
without
mscev
h
influenza
viru
nucleoprotein
np
detect
use
antinp
monoclon
antibodi
immunofluoresc
assay
ifa
cell
express
np
protein
count
least
five
microscop
field
viru
titer
cultur
supernat
determin
titrat
mdck
cell
h
infect
apoptot
cell
detect
tunel
assay
use
apoptag
fluorescein
apoptosi
detect
kit
emd
millipor
apoptot
cell
count
five
microscop
field
data
express
mean
sd
number
apoptot
cell
microscop
field
second
set
experi
lec
infect
swiv
moi
h
follow
wash
pb
lec
incub
without
mscev
h
influenzainfect
cell
detect
express
np
ifa
experi
mscev
treat
u
ml
rnase
h
uml
rnase
ad
stop
reaction
mscev
wash
ultracentrifug
lec
wash
pb
fix
aceton
min
express
influenza
viru
np
infect
cell
detect
use
mous
antinp
antibodi
primari
antibodi
alexa
goat
antimous
igg
secondari
antibodi
nuclei
stain
dapi
thermofish
scientif
life
scienc
fiveweekold
convent
larg
whiteduroc
crossbr
pig
obtain
osu
herd
mainten
pig
experiment
procedur
conduct
accord
guidelin
institut
laboratori
anim
care
use
committe
ohio
state
univers
protocol
week
age
nine
pig
mean
weight
kg
divid
three
group
three
pig
pig
group
inocul
intranas
dmem
pig
serv
control
pig
group
similarli
inocul
swiv
tcid
per
pig
pig
hemagglutin
inhibit
hi
antibodi
titer
swiv
infect
previou
studi
infect
commerci
pig
swiv
tcid
per
pig
induc
extens
lung
lesion
twelv
hour
swiv
infect
pig
group
administ
intratrach
dmem
mscev
bodi
weight
bw
respect
human
clinic
trial
ard
msc
cellskg
bw
use
studi
ev
dose
per
kg
bw
calcul
protein
content
ev
produc
msc
cultur
h
previou
studi
intratrach
administ
ev
effect
treat
e
coliinduc
sever
pneumonia
base
observ
studi
ev
administ
intratrach
rout
pig
monitor
daili
clinic
sign
nasal
swab
collect
day
postinfect
dpi
viru
titrat
mdck
cell
dpi
pig
euthan
lung
harvest
lung
lysat
prepar
left
lung
viru
quantif
cytokin
analysi
entir
right
lung
fix
buffer
formalin
microscop
examin
timepoint
dpi
select
base
earlier
public
show
higher
viru
replic
proinflammatori
cytokin
product
dpi
compar
dpi
paraffinembed
section
lung
tissu
stain
hematoxylin
eosin
examin
help
train
pathologist
awar
experiment
design
slide
examin
bronchiolar
epitheli
chang
peribronchiolar
inflamm
interstiti
pneumonia
lesion
score
describ
previous
wv
lung
homogen
prepar
left
apic
lobe
lung
tissu
viru
titer
determin
titrat
mdck
cell
describ
viru
titer
calcul
reed
muench
method
lung
lysat
pig
prepar
level
tumor
necrosi
factor
tnf
interleukin
il
lung
lysat
determin
enzymelink
immunosorb
assay
elisa
describ
previous
vitro
data
mscevmedi
inhibit
swiv
replic
analyz
student
test
microscop
lung
lesion
viru
titer
cytokin
concentr
group
pig
compar
use
kruskalw
test
p
valu
consid
statist
signific
isol
msc
bm
pig
show
characterist
featur
msc
adher
plastic
surfac
fibroblastlik
morpholog
fig
selfrenew
potenti
high
vitro
prolifer
capac
differenti
potenti
data
shown
colonyexpand
msc
show
express
mesenchym
marker
slai
slaii
detect
cell
mscev
roundshap
similarli
msc
ev
isol
bmmsc
also
express
mesenchym
marker
howev
unlik
msc
lack
express
slai
ii
fig
mscev
also
express
evspecif
marker
fig
also
determin
rna
protein
concentr
mscev
mscev
contain
ev
n
total
rna
ev
n
total
protein
addit
mscev
show
abil
incorpor
lec
ev
stain
red
dye
found
insid
cytoplasm
cell
examin
fluoresc
microscop
incorpor
mscev
lec
also
confirm
flow
cytometri
fig
determin
mscev
possess
antiinfluenza
activ
first
examin
ev
inhibit
ha
activ
influenza
virus
eight
ha
unit
chicken
influenza
virus
incub
differ
concentr
mscev
ha
activ
virus
examin
mscev
concentr
complet
inhibit
ha
activ
virus
tabl
examin
mscev
deriv
bmmsc
antiinfluenza
activ
swiv
moi
incub
mscev
min
room
temperatur
lec
infect
evswiv
mixtur
viru
h
infect
iavnp
detect
ifa
fig
c
significantli
reduc
p
influenza
replic
detect
cell
infect
swiv
pretreat
mscev
consist
reduc
influenza
viru
replic
lec
treat
mscev
mscev
also
significantli
p
inhibit
apoptosi
influenzainfect
lec
fig
b
anoth
set
experi
porcin
lung
epitheli
lec
infect
swiv
h
wash
incub
media
without
mscev
h
infect
iavnp
detect
ifa
addit
mscev
viru
entri
significantli
p
reduc
influenza
replic
lec
fig
examin
antiinfluenza
immunomodulatori
effect
mscev
influenza
virusinduc
ali
pig
eightweekold
pig
infect
intranas
tcid
swiv
twelv
hour
swiv
inocul
dmem
mscev
administ
intratrach
influenzainfect
pig
day
ev
administr
collect
nasal
swab
day
ev
administr
pig
euthan
bronchoalveolar
lavag
bal
lung
collect
lung
homogen
make
lung
lysat
determin
viru
titer
cytokin
examin
lung
lysat
swiv
induc
extens
lung
lesion
infect
pig
determin
infiltr
inflammatori
cell
thicken
alveolar
wall
collaps
alveoli
wherea
lung
pig
administ
mscev
show
minor
infiltr
inflammatori
cell
mean
microscop
lung
lesion
score
swiv
dmem
inocul
pig
compar
swiv
ev
administ
group
fig
consist
inflammatori
lesion
lung
level
total
protein
bal
swiv
ev
administ
pig
also
lower
level
swiv
dmem
inocul
pig
fig
detect
influenza
viru
shed
nasal
swab
day
ev
administr
viru
shed
lower
evadminist
group
day
postev
administr
compar
swiv
dmem
inocul
pig
fig
similarli
viru
titer
also
lower
lung
lysat
evadminist
pig
data
suggest
mscev
inhibit
influenza
viru
replic
shed
pig
next
examin
mscev
also
modul
inflammatori
cytokin
product
lung
mscev
administ
group
level
pgg
lung
lysat
compar
pgg
pig
inocul
swiv
dmem
similarli
level
swiv
ev
administ
pig
pgg
compar
pgg
lung
lysat
swiv
dmem
inocul
pig
level
antiinflammatori
cytokin
slightli
higher
swiv
ev
administ
group
compar
swiv
dmem
inocul
pig
fig
find
suggest
mscev
possess
antiinfluenza
antiinflammatori
properti
attenu
influenza
virusinduc
ali
pig
model
isol
character
ev
porcin
bmmsc
use
protocol
describ
human
mscderiv
ev
human
mscev
also
use
tem
determin
size
morpholog
mscev
size
distribut
human
mscev
also
determin
nanotrack
techniqu
use
studi
human
mscderiv
ev
express
mesenchym
marker
lack
express
mhc
molecul
studi
pig
mscderiv
ev
also
express
mesenchym
marker
express
slai
ii
detect
ev
suggest
pig
mscev
similar
human
mscev
use
understand
mechan
mscevmedi
therapeut
effect
pig
model
human
diseas
number
studi
demonstr
benefici
effect
mscev
vitro
anim
model
lung
kidney
liver
diseas
furthermor
sever
studi
shown
ev
exert
therapeut
effect
transfer
mrna
diseas
cell
studi
antiinfluenza
viru
activ
mscev
lung
epitheli
cell
mediat
mrna
content
pretreat
ev
rnase
enzym
abrog
antiinfluenza
viru
activ
ev
recent
studi
qian
colleagu
demonstr
exosom
exo
isol
umbil
cordderiv
msc
inhibit
replic
hepat
c
viru
hcv
human
dermal
fibroblast
cell
author
identifi
four
mscexospecif
mirna
antihcv
activ
mscevspecif
mirna
also
implic
regul
cell
surviv
differenti
immunomodul
futur
studi
focu
identifi
mscevspecif
mrna
mirna
may
play
role
regul
antiinfluenza
activ
mscev
one
mechan
influenza
virus
caus
extens
lung
damag
mortal
due
induct
unregul
inflammatori
respons
similarli
msc
mscderiv
ev
also
possess
immunomodulatori
activ
studi
mscev
inocul
pig
show
significantli
less
lung
inflamm
decreas
level
proinflammatori
cytokin
chemokin
product
addit
increas
level
antiinflammatori
cytokin
observ
mscev
administ
pig
data
suggest
addit
antiinfluenza
activ
mscev
also
exert
immunomodulatori
activ
suppress
inflammatori
respons
influenza
similar
find
mscev
caus
decreas
product
inflammatori
cytokin
increas
product
mous
model
ard
monsel
colleagu
demonstr
mscev
express
cyclooxygenas
cox
mrna
enzym
induc
prostaglandin
synthesi
secret
msc
shown
reprogram
proinflammatori
monocytemacrophag
antiinflammatori
type
produc
high
level
addit
mscev
interact
immun
cell
caus
product
transform
growth
factor
tgf
tregulatori
cell
treg
treg
promot
viru
clearanc
recoveri
influenza
virusinfect
mice
futur
studi
examin
whether
mscev
treatment
induc
gener
macrophag
treg
pig
model
influenza
viru
msc
mediat
immunomodulatori
tissu
repair
function
releas
numer
therapeut
solubl
factor
indoleamin
ido
produc
msc
modul
function
immun
cell
inhibit
influenza
viru
replic
similarli
antimicrobi
peptid
produc
msc
shown
inhibit
growth
sever
speci
bacteria
also
inhibit
replic
influenza
viru
addit
also
shown
regul
immunomodulatori
activ
msc
current
data
whether
ido
transfer
msc
secret
ev
avail
examin
studi
may
possibl
factor
may
involv
mediat
antiinfluenza
antiinflammatori
activ
mscev
influenza
model
recent
studi
examin
therapeut
potenti
msc
influenza
mice
conflict
result
lile
matthay
group
report
mous
human
msc
fail
prevent
influenza
virusinduc
mortal
ali
mice
recent
two
public
shown
msc
reduc
influenza
virusinduc
ali
mice
infect
hpai
without
affect
viru
replic
other
shown
previous
influenza
viru
infect
msc
infect
msc
produc
inflammatori
cytokin
vivo
studi
examin
therapeut
efficaci
msc
influenza
virusinduc
ali
none
examin
infect
administ
msc
influenza
viru
replic
viru
influenza
virusinfect
mice
may
infect
inject
msc
virusinfect
msc
may
function
effect
inhibit
viru
replic
inflamm
invitro
studi
influenza
viru
infect
caus
apoptosi
lysi
infect
msc
inactiv
msc
shown
retain
immunomodulatori
function
heatinactiv
msc
modul
function
monocytesmacrophag
effect
b
cell
studi
demonstr
protect
effect
transplant
msc
influenza
virusinfect
mice
antiinflammatori
fig
effect
mscev
administr
viru
titer
nasal
swab
lung
pig
infect
swiv
eightweekold
pig
mock
infect
infect
swiv
h
pig
administ
intratrach
dulbecco
modifi
eagl
medium
dmem
msc
extracellular
vesicl
ev
nasal
swab
collect
infect
pig
day
ev
administr
day
ev
administr
pig
euthan
lung
harvest
lung
tissu
homogen
prepar
lung
lysat
influenza
viru
shed
nasal
swab
viru
titer
lung
determin
titrat
mdck
cell
valu
bar
indic
mean
viru
titer
three
pig
sd
fig
effect
mscev
administr
cytokin
product
lung
swivinfect
pig
eightweekold
pig
mock
infect
infect
swiv
h
pig
administ
intratrach
dulbecco
modifi
eagl
medium
dmem
msc
extracellular
vesicl
ev
three
day
ev
administr
pig
euthan
cytokin
product
lung
lysat
analyz
elisa
bar
repres
mean
concentr
cytokin
sd
three
pig
il
interleukin
tnf
tumor
necrosi
factor
effect
observ
studi
may
like
mediat
influenzainfect
dead
apoptot
msc
futur
experi
requir
confirm
infect
transplant
msc
influenza
viru
examin
interact
immun
cell
anim
model
influenza
viru
mscev
recent
identifi
equal
effect
msc
treat
endotoxin
e
coliinduc
ali
rodent
model
demonstr
mscev
attenu
influenza
virusinduc
ali
pig
model
importantli
administr
mscev
safe
sinc
gross
patholog
lesion
observ
intern
organ
pig
addit
mscev
treatment
also
found
safe
human
patient
treat
graftversushost
diseas
gvhd
chronic
kidney
diseas
thu
find
studi
may
help
plan
futur
clinic
trial
human
use
mscev
cellfre
therapi
ard
mscev
offer
sever
advantag
msc
therapi
human
diseas
although
msc
proven
effect
safe
treat
sever
human
condit
anim
model
clinic
trial
safeti
concern
pulmonari
embol
uncontrol
differenti
tumor
format
still
associ
use
msc
therapi
human
hand
use
ev
therapi
found
safer
msc
ev
stabl
circul
due
lipid
membran
risk
aneuploidi
well
toler
recipi
due
small
size
lack
express
mhc
molecul
moreov
ev
store
without
lose
biochem
activ
thu
ev
potenti
becom
safe
effect
cellfre
therapi
human
diseas
howev
number
challeng
standard
protocol
product
clinic
grade
ev
dose
qualiti
control
storag
condit
still
need
address
mscev
advanc
clinic
studi
certain
limit
addit
control
group
consist
ev
deriv
fibroblast
need
confirm
benefici
effect
influenza
specif
mediat
mscev
administr
ev
intraven
rout
would
relev
clinic
set
howev
sever
studi
ev
obtain
msc
fibroblast
show
benefici
effect
ard
inocul
intraven
intratrach
preliminari
studi
pig
model
lipopolysaccharid
lp
induc
ard
human
mscderiv
ev
ev
normal
human
lung
fibroblast
attenu
lung
inflamm
summari
ev
deriv
porcin
bmmsc
express
mesenchym
marker
inhibit
influenza
viru
replic
vitro
vivo
attenu
influenza
virusinduc
ali
relev
preclin
larg
anim
model
find
suggest
mscev
may
potenti
cellfre
therapi
acut
inflammatori
diseas
includ
influenza
